계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Evofem Biosciences
company
About
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $8M
- Industries
- Biopharma,Health Care,Medical,Women's
- Founded date
- Jan 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$28.60M
Evofem Biosciences has raised a total of
$28.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 12, 2014 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 12, 2014 | Series C | $8M | 1 | — | — | Detail |
| Dec 19, 2012 | Series C | $20.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Evofem Biosciences is funded by 2 investors.
AKS Capital
and Numoda Capital Innovations
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Numoda Capital Innovations
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
